TrialInternational journal of radiation oncology, biology, physics2026
Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer.
Jyoti Mayadev et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.